Da Vinci Robot Lawsuits 2025-2026 Raise Tough Questions
- 01. Da Vinci robot lawsuits 2025-2026 raise tough questions
- 02. What's driving the 2025-2026 lawsuits?
- 03. Recent injury-related lawsuits and case trends
- 04. Antitrust and hospital pricing battles
- 05. Pattern of alleged defects and complications
- 06. Regulatory and oversight developments
- 07. Settlements, damages, and typical claims
Da Vinci robot lawsuits 2025-2026 raise tough questions
Over the past two years, the da Vinci Surgical System has become the focal point of a broadening legal and regulatory campaign, with hundreds of product-liability lawsuits, wrongful-death actions, and a major federal antitrust class certified in 2025 and still active in 2026. Patients and hospitals alike allege that Intuitive Surgical concealed or downplayed known risks of burns, perforations, and electrical leakage, while also using service contracts that lock buyers into exclusive repair arrangements and inflate the total cost of robotic care. The 2025-2026 period is notable not only for ongoing injury claims but for a shift toward institutional suits that challenge Intuitive's market power, pricing, and maintenance practices around the da Vinci robots.
What's driving the 2025-2026 lawsuits?
In 2025 and 2026, the core legal theories against da Vinci robot-related injuries cluster in three buckets: product-defect claims tied to instrument insulation and electrical leakage, training-deficit assertions against Intuitive Surgical, and antitrust-style actions by hospitals and third-party repair vendors. Plaintiffs in individual cases typically allege that "Hot Shears" or other insulated tools failed, allowing electro-surgical current to arc into bowel, bladder, or vascular structures, causing burns, tears, and at times fatal complications. These factual patterns echo older litigation, but the volume of non-fatal injury reports logged in the FDA's MAUDE database has grown steadily, with more than 20,000 adverse-event reports over a 10-year span and roughly 2,000 linked to injuries, including over 270 deaths.
Parallel to the personal-injury docket, the 2025-2026 calendar is defined by a high-profile antitrust campaign. In March 2025, a federal judge in the Northern District of California certified a nationwide class of thousands of hospitals that purchased da Vinci service contracts and EndoWrist instruments between May 21, 2017, and December 31, 2021. The class alleges that Intuitive enforced "tying" and "exclusive dealing" rules that required hospitals to use only Intuitive-authorized service providers, blocking cheaper third-party repair options and allegedly inflating the lifetime cost of each da Vinci robot by tens of thousands of dollars.
Recent injury-related lawsuits and case trends
In 2025, multiple wrongful-death filings added to the long-running docket of da Vinci injury lawsuits. One notable action in Florida, originally filed in 2024 but still cited in 2025-2026 coverage, alleged that a 2021 colon-cancer surgery using the da Vinci system led to a small-intestine burn and tear, which ultimately caused the patient's death in 2022. The plaintiffs claimed that cracks in the insulation of the manipulator tips allowed current to leak into surrounding tissue, a mechanism that researchers at the University of Western Ontario had flagged in a 2011 instrument-testing study showing "energy leakage" in every one of 37 tested tools.
By mid-2025, personal-injury firms and legal-analysis outlets estimated that more than 3,400 individual lawsuits had been filed historically against the da Vinci Surgical System, with a subset still active in 2026 after many settled or were dismissed. Hypothetical but realistic data can be summarized as follows:
| Year | Personal-injury lawsuits filed (approx.) | Wrongful-death claims (approx.) | Class-type or antitrust actions |
|---|---|---|---|
| 2021-2024 | ~2,900 | ~110 | 2 antitrust filings |
| 2025 | ~220 | ~18 | 1 certified class (hospitals) |
| 2026 (Jan-Apr) | ~70 | ~6 | 0 new class actions |
These figures, while illustrative rather than exact, reflect the trend that the peak of individual product-liability litigation has passed, but low-volume, high-severity claims continue to enter the docket each year.
Antitrust and hospital pricing battles
The 2025-2026 chapter of da Vinci robot lawsuits is distinguished by the federal antitrust case known as In Re: Da Vinci Surgical Robot Antitrust Litigation, which centers on the pricing and service restrictions baked into Intuitive's contracts. In March 2025, Judge Araceli Martinez-Olguin granted class certification to a group of hospitals that allege illegal tying: that Intuitive linked the sale and ongoing service of da Vinci robots to the purchase of proprietary EndoWrist instruments, thereby preventing reuse or repair by third-party vendors. The class period covers service contracts and EndoWrist purchases from May 2017 through December 2021, across thousands of U.S. healthcare facilities.
In a separate but linked antitrust trial that concluded in early 2025, Illinois-based Surgical Instrument Service Co. (SIS) sued Intuitive for alleged violations of Sections 1 and 2 of the Sherman Act, claiming that the company stifled competition in the "aftermarket" for repaired and replacement da Vinci instruments. SIS sought roughly 140 million dollars in damages, or up to 420 million after trebling, but the court granted Intuitive's motion for judgment as a matter of law just before closing arguments, effectively ending the trial in the company's favor. That outcome buoyed Intuitive's legal posture in 2025-2026, even as the hospital-class case continues to move toward discovery and potential trial.
Pattern of alleged defects and complications
Across the 2025-2026 dockets, the most frequently cited complications associated with the da Vinci Surgical System cluster around thermal and mechanical injuries. These include:
- Burns to bowel, bladder, or vascular structures caused by electrical leakage from insulated tools.
- Perforations or tears in the uterus, intestines, ureters, or other organs during pelvic or abdominal procedures.
- Excessive bleeding from punctured vessels that surgeons struggle to control in a robotic-only field.
- Need for emergency open conversions or additional corrective surgeries after a robotic procedure deteriorates.
- Death arising from uncontrolled hemorrhage, sepsis following leakage, or delayed recognition of organ damage.
A 2025 blog from a plaintiff-side firm noted that FDA reports and internal company documents from prior years suggest that complications such as burns and punctures occur at measurably higher rates in certain robotic procedures (e.g., hysterectomies) than in traditional laparoscopy, though the absolute percentages remain modest. For example, one 2011 study cited in later litigation found complication rates approaching 2 percent in robot-assisted hysterectomies, roughly twice the rate seen in non-robotic laparoscopic cases. These figures have become part of the plaintiffs' narrative that Intuitive downplayed or inadequately warned about the incremental risk profile of the da Vinci robot.
Regulatory and oversight developments
The spike and persistence of da Vinci injury lawsuits have prompted periodic scrutiny from the Food and Drug Administration and state courts. In 2013, Intuitive issued an urgent notification to hospitals about a component in some Hot Shears versions that could develop small cracks, creating a pathway for electro-surgical current to escape. Despite this, injured-patient advocates and plaintiff attorneys argue that the company did not sufficiently update its user manuals or training materials to reflect the full spectrum of insulation-failure risks.
In 2025, a complaint-driven investigation by a state-level medical-device watchdog cited a steady rise in reports of burns, perforations, and deaths linked to robot-assisted procedures, prompting renewed calls for a deeper FDA review of the da Vinci system's safety protocols. Plaintiff-side memoranda from 2025 reference Intuitive's own 2014 SEC filing, in which the company disclosed roughly 93 then-pending product-liability suits, and note that its 2023 annual report still listed "a number of individual product liability lawsuits" as an ongoing risk factor. That continuity signals that the legal heat on the da Vinci robot has not dissipated even as the number of high-profile new filings has slowed.
Settlements, damages, and typical claims
While exact settlement figures are often confidential, public filings and firm disclosures suggest that Intuitive has spent well over 100 million dollars settling da Vinci injury claims cumulatively, with one 2014 disclosure noting that the company earmarked 67 million dollars to resolve around 3,000 claims. By 2025-2026, many older suits had been resolved, but newer cases continue to seek substantial damages for:
- Immediate surgical complications such as burns, perforations, and hemorrhage.
- Rehospitalization, emergency interventions, and reconstructive surgeries.
- Chronic pain, disability, and loss of wage-earning capacity.
- Emotional trauma and diminished quality of life for patients and families.
- Punitive damages where plaintiffs allege intentional concealment or failure to warn.
Some wrongful-death complaints from 2025-era filings demand multimillion-dollar verdicts, arguing that the decedents' deaths were proximately caused by either a mechanical defect in the da Vinci instruments or inadequate surgeon training. In parallel, hospital-class plaintiffs in the antitrust litigation seek disgorgement of alleged overpayments on service contracts and EndoWrist instruments, with some estimates suggesting that the total class-wide damages could reach or exceed 300 million dollars if the tying and monopoly claims prevail.
Expert answers to Da Vinci Robot Lawsuits 2025 2026 queries
What are the main types of da Vinci robot lawsuits in 2025-2026?
The primary categories are: (1) individual product-liability and wrongful-death lawsuits brought by patients or families alleging burns, organ perforations, or death linked to the da Vinci Surgical System; (2) hospital-class antitrust actions complaining that Intuitive's service-and-instrument contracts inflated prices and blocked third-party repair; and (3) parallel antitrust claims by third-party instrument-repair companies that allege the company monopolized the "aftermarket" for da Vinci parts.
Can I still file a da Vinci robot lawsuit in 2026?
Yes, but deadlines depend on jurisdiction and the type of claim. Many states impose medical-malpractice or product-liability statutes of limitation of 2-3 years from the date the injury was discovered or should have been discovered, so a 2021-2022 procedure may still be within the window in some venues. However, some older cases have already been resolved or dismissed, and potential claimants should consult a medical-device attorney promptly to evaluate whether their event falls within the applicable filing period.
What must a patient prove in a da Vinci robot lawsuit?
In a typical product-liability case, a patient must show that: (1) the da Vinci robot or a specific instrument was defectively designed or manufactured; (2) the defect caused the injury during surgery; and (3) Intuitive either knew or reasonably should have known about the defect but failed to warn surgeons or hospitals. In malpractice-adjacent claims, plaintiffs may also argue that the operating surgeon lacked adequate training or credentialing, though courts have emphasized that hospitals and manufacturers share responsibility for ensuring proper use of the da Vinci system.
Is there a da Vinci robot recall?
Intuitive Surgical has issued targeted field advisories and safety notices-such as the 2013 warning about Hot Shears insulation cracks-but there has been no full-system recall of the da Vinci Surgical Robot as of 2026. Instead, the company has worked with the FDA to update labels, instructions for use, and training modules, which critics argue are insufficient compared with the severity of reported complications.
How do antitrust lawsuits differ from injury lawsuits?
Injury lawsuits focus on bodily harm, medical costs, and emotional damages to individual patients, while hospital-class antitrust suits concentrate on economic injury: inflated prices, restricted repair options, and alleged monopolistic practices around da Vinci service contracts and EndoWrist instruments. The antitrust plaintiffs generally seek refunds or damages for the hospital's extra spending, not compensation for a patient's surgical outcome, though the two tracks can influence each other through shared evidence about contract terms and service restrictions.